| scholarly article | Q13442814 |
| P50 | author | Florian Herse | Q47804678 |
| Gerd Wallukat | Q63288594 | ||
| Ralf Dechend | Q63812628 | ||
| Babbette LaMarca | Q88459247 | ||
| P2093 | author name string | Jeremy Scott | |
| James N Martin | |||
| Kedra Wallace | |||
| Judith Heath | |||
| Janae Mosely | |||
| Pushpinder Dhillion | |||
| P2860 | cites work | Interleukin 17 promotes angiotensin II-induced hypertension and vascular dysfunction | Q33642021 |
| Summary of the NHLBI Working Group on Research on Hypertension During Pregnancy | Q34182166 | ||
| Hypertension in response to placental ischemia during pregnancy: role of B lymphocytes | Q35029700 | ||
| Angiotensin II type 1 autoantibody induced hypertension during pregnancy is associated with renal endothelial dysfunction | Q35576417 | ||
| Activating autoantibodies to the angiotensin II type I receptor play an important role in mediating hypertension in response to adoptive transfer of CD4+ T lymphocytes from placental ischemic rats | Q35994304 | ||
| Hypertension in response to IL-6 during pregnancy: role of AT1-receptor activation | Q36244980 | ||
| Agonistic antibodies directed at the angiotensin II, AT1 receptor in preeclampsia | Q36380482 | ||
| The effect of immune factors, tumor necrosis factor-alpha, and agonistic autoantibodies to the angiotensin II type I receptor on soluble fms-like tyrosine-1 and soluble endoglin production in response to hypertension during pregnancy | Q36407259 | ||
| Immunoregulation in normal pregnancy and pre-eclampsia: an overview | Q36684096 | ||
| The role of immune activation in contributing to vascular dysfunction and the pathophysiology of hypertension during preeclampsia | Q37088970 | ||
| Inhibition of Th17 cells regulates autoimmune diabetes in NOD mice. | Q37193763 | ||
| Hypertension in response to autoantibodies to the angiotensin II type I receptor (AT1-AA) in pregnant rats: role of endothelin-1. | Q37447371 | ||
| Interleukin-17-producing T cells in lupus | Q37769076 | ||
| Current perspectives on the role of IL-17 in autoimmune disease | Q39181014 | ||
| Systemic increase in the ratio between Foxp3+ and IL-17-producing CD4+ T cells in healthy pregnancy but not in preeclampsia | Q46332630 | ||
| AT(1) receptor agonistic antibodies from preeclamptic patients cause vascular cells to express tissue factor | Q73815485 | ||
| Pathophysiology of pregnancy-induced hypertension | Q74039094 | ||
| Hypertension in response to AT1-AA: role of reactive oxygen species in pregnancy-induced hypertension | Q83799951 | ||
| P433 | issue | 4 | |
| P921 | main subject | hypertension | Q95566669 |
| P304 | page(s) | R353-8 | |
| P577 | publication date | 2012-06-20 | |
| P1433 | published in | American Journal of Physiology - Regulatory, Integrative and Comparative Physiology | Q2201819 |
| P1476 | title | IL-17-mediated oxidative stress is an important stimulator of AT1-AA and hypertension during pregnancy | |
| P478 | volume | 303 |
| Q53700889 | AT1-AA (Angiotensin II Type 1 Receptor Agonistic Autoantibody) Blockade Prevents Preeclamptic Symptoms in Placental Ischemic Rats. |
| Q38118625 | Activating autoantibodies and cardiovascular disease |
| Q37507162 | Administration of interleukin-17 soluble receptor C suppresses TH17 cells, oxidative stress, and hypertension in response to placental ischemia during pregnancy |
| Q34541831 | Agonistic Autoantibodies to the Angiotensin II Type 1 Receptor Enhance Angiotensin II-Induced Renal Vascular Sensitivity and Reduce Renal Function During Pregnancy |
| Q33645466 | Analysis of Serum Cytokines and Single-Nucleotide Polymorphisms of SOD1, SOD2, and CAT in Erysipelas Patients. |
| Q27027039 | Angiotensin receptor agonistic autoantibodies and hypertension: preeclampsia and beyond |
| Q35116086 | Autoimmunity: an underlying factor in the pathogenesis of hypertension |
| Q37497841 | B-1a B cells regulate T cell differentiation associated with pregnancy disturbances |
| Q28083815 | Bioactive factors in uteroplacental and systemic circulation link placental ischemia to generalized vascular dysfunction in hypertensive pregnancy and preeclampsia |
| Q35153877 | CD4+ T cells are important mediators of oxidative stress that cause hypertension in response to placental ischemia. |
| Q64068024 | Chronic infusion of interleukin-17 promotes hypertension, activation of cytolytic natural killer cells, and vascular dysfunction in pregnant rats |
| Q89780531 | Chronic maternal interleukin-17 and autism-related cortical gene expression, neurobiology, and behavior |
| Q38430192 | Consensus strategy in genes prioritization and combined bioinformatics analysis for preeclampsia pathogenesis |
| Q36836373 | Elevated Transglutaminase Activity Triggers Angiotensin Receptor Activating Autoantibody Production and Pathophysiology of Preeclampsia |
| Q26852668 | Elucidating immune mechanisms causing hypertension during pregnancy |
| Q34533218 | Endothelin-1 is not a Mechanism of IL-17 Induced Hypertension during Pregnancy. |
| Q33740993 | Excess LIGHT contributes to placental impairment, increased secretion of vasoactive factors, hypertension, and proteinuria in preeclampsia |
| Q40779892 | Hypertension in an Animal Model of HELLP Syndrome is Associated With Activation of Endothelin 1. |
| Q34025660 | Hypertension, inflammation and T lymphocytes are increased in a rat model of HELLP syndrome |
| Q36997267 | IL-10 supplementation increases Tregs and decreases hypertension in the RUPP rat model of preeclampsia |
| Q37139722 | Identifying immune mechanisms mediating the hypertension during preeclampsia |
| Q49600503 | Immune regulation of systemic hypertension, pulmonary arterial hypertension, and preeclampsia: shared disease mechanisms and translational opportunities |
| Q39198610 | Inflammation, Autoimmunity, and Hypertension: The Essential Role of Tissue Transglutaminase |
| Q38543831 | Linking the old and new -- do angiotensin II type 1 receptor antibodies provide the missing link in the pathophysiology of preeclampsia? |
| Q37483159 | Magnesium Sulfate Prevents Placental Ischemia-Induced Increases in Brain Water Content and Cerebrospinal Fluid Cytokines in Pregnant Rats |
| Q46300954 | Natural killer cells and T lymphocytes in pregnancy and pre-eclampsia |
| Q90628338 | Neurodevelopmental Outcomes of Prenatal Preeclampsia Exposure |
| Q36531431 | Neurokinin 3 receptor and phosphocholine transferase: missing factors for pathogenesis of C-reactive protein in preeclampsia |
| Q45763187 | Overexpression of CD39 protects in a mouse model of preeclampsia |
| Q38641180 | Oxidative Stress: Placenta Function and Dysfunction |
| Q39423454 | Pathophysiology and Current Clinical Management of Preeclampsia |
| Q60912330 | Peripheral Anti-Angiogenic Imbalance during Pregnancy Impairs Myogenic Tone and Increases Cerebral Edema in a Rodent Model of HELLP Syndrome |
| Q92071244 | Placental CD4+ T cells isolated from preeclamptic women cause preeclampsia-like symptoms in pregnant nude-athymic rats |
| Q37451544 | Placental Ischemia and Resultant Phenotype in Animal Models of Preeclampsia |
| Q36357583 | Placental ischemia increases seizure susceptibility and cerebrospinal fluid cytokines |
| Q88542480 | Placental ischemia-stimulated T-helper 17 cells induce preeclampsia-associated cytolytic natural killer cells during pregnancy |
| Q34657074 | Plasma IL-17, IL-35, interferon-γ, SOCS3 and TGF-β levels in pregnant women with preeclampsia, and their relation with severity of disease |
| Q88194244 | Postpartum increases in cerebral edema and inflammation in response to placental ischemia during pregnancy |
| Q33416340 | Pre-eclampsia part 1: current understanding of its pathophysiology |
| Q57055935 | Pre-eclampsia: the role of highly active antiretroviral therapy and immune markers |
| Q48523077 | Preeclampsia: From Inflammation to Immunoregulation |
| Q26800272 | Preeclampsia: long-term consequences for vascular health |
| Q45848306 | Reduced uterine perfusion pressure T-helper 17 cells cause pathophysiology associated with preeclampsia during pregnancy |
| Q92071252 | Renal natural killer cell activation and mitochondrial oxidative stress; new mechanisms in AT1-AA mediated hypertensive pregnancy |
| Q35801516 | Role of IL-17 Variants in Preeclampsia in Chinese Han Women |
| Q37385038 | TH17- and IL-17- mediated autoantibodies and placental oxidative stress play a role in the pathophysiology of pre-eclampsia |
| Q26742118 | The Predictive Role of Inflammatory Biomarkers in Atrial Fibrillation as Seen through Neutrophil-Lymphocyte Ratio Mirror |
| Q33862263 | The Role of Interleukin-17, Interleukin-23, and Transforming Growth Factor-β in Pregnancy Complicated by Placental Insufficiency |
| Q33957722 | The immune system in hypertension |
| Q53064232 | The immune system in hypertension. |
| Q27003301 | The renal circulation in normal pregnancy and preeclampsia: is there a place for relaxin? |
| Q57150158 | The role of Agonistic Autoantibodies to the Angiotensin II Type 1 Receptor (AT1-AA) in Pathophysiology of Preeclampsia |
| Q33834419 | The role of inflammation in the pathology of preeclampsia |
| Q37240779 | Transglutaminase is a Critical Link Between Inflammation and Hypertension |
Search more.